Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer

PURPOSE: There is currently no imaging biomarker for metastatic prostate cancer. The bone scan index (BSI) is a promising candidate, being a reproducible, quantitative expression of tumor burden seen on bone scintigraphy. Prior studies have shown the prognostic value of a baseline BSI. This study te...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dennis, Elizabeth R., Jia, Xiaoyu, Mezheritskiy, Irina S., Stephenson, Ryan D., Schoder, Heiko, Fox, Josef J., Heller, Glenn, Scher, Howard I., Larson, Steven M., Morris, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295554/
https://ncbi.nlm.nih.gov/pubmed/22231045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.36.5791
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares